Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Science & Space, Education.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H332A432E135B4D7E9E9BB6AFBC613EF9: 1. Short title This Act may be cited as the Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023 or the TRANQ Research Act of 2023.
- Section H8C31561D5F8F438AA4AD2411758D29AA: 2. Xylazine detection and analysis In this section: The term Director means the Director of the National Institute of Standards and Technology. The term...
- Section H8F706DE045D04304BACA99FDB24275CF: 3. Study on United States Government technologies and analytical methods to detect and identify new psychoactive substances The Comptroller General of the...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Science & Space, Education
Primary Purpose
This bill, Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
ReportedReceived
Additional sponsors: Mr. C. Scott Franklin of Florida, Mr. Miller …
Reported with an amendment, committed to the Committee of the …
Mr. Collins (for himself, Ms. Caraveo, Mr. Lucas, Ms. Lofgren, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology